Investigational Drug Details
| Drug ID: | D477 |
| Drug Name: | FM101 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | A3 adenosine receptor modulator |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 on-going (NCT04710524) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0032 | NCT04710524 | Phase 2 | Recruiting | No Results Available | June 10, 2021 | March 7, 2022 | Details |
| L0230 | EUCTR2020-005187-63-ES | Phase 2 | Authorised | No Results Available | 01/09/2021 | 7 September 2021 | Details |
| L0396 | EUCTR2020-005187-63-HU | Phase 2 | Authorised | No Results Available | 11/02/2021 | 26 April 2021 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|